Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 5009
Out of 5,441 analysts
106
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
QTRX Quanterix
Downgrades: Hold
12 5
4.58 9.17% 7 Aug 11, 2025
ILMN Illumina
Maintains: Hold
99 105
94.79 10.77% 12 Aug 1, 2025
XGN Exagen
Maintains: Strong Buy
8 11
9.38 17.27% 4 Jul 30, 2025
AKYA Akoya Biosciences
Maintains: Hold
2 2
1.29 -16.28% 5 May 19, 2025
GRAL GRAIL
Maintains: Strong Buy
32 43
32.73 31.38% 2 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
n/a n/a 4 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 15
12.31 21.85% 8 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 37
19.13 93.41% 4 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
60 65
54.81 18.59% 7 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
170 150
111.93 34.01% 3 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.25 140% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
180 195
157.12 24.11% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1 200% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.2 -16.67% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
40.92 83.28% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
n/a n/a 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
26.08 -0.31% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
2.1 19.05% 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.62 222.58% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
3.87 390.96% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
n/a n/a 1 Jan 29, 2021